Industry News Roundup – June 2024

Gencor’s Levagen+ supports exercise performance, study finds
A human study on Levagen+ (PEA) determined that the ingredient can positively impact exercise performance whilst not interfering with muscle hypertrophy. The results showed a 350mg dose of Levagen+ improves lower body power and isometric strength by 12%.
Read more

Givaudan reveals new clinical research on Pacran’s urinary tract health benefits
Givaudan detailed the latest clinical trial results supporting the efficacy and reliability of Pacran, the company’s cranberry ingredient for urinary tract health. The research confirmed earlier findings, revealing that 500 mg of Pacran daily could reduce recurrent urinary tract infections and improve other urinary tract health indicators.
Read more

Nestlé Health Science kicks off clinical trial on mild cognitive impairment
Nestlé Health Science is investigating the benefits of a specialized ketogenic product, BrainXpert, on mild cognitive impairment (MCI). This nutritional product is intended to be used as a food for special medical purposes or medical food to support cognitive function for people with MCI. The trial will investigate whether BrainXpert could be an alternative fuel source to glucose and provide brain cell support. It will include approximately 380 people with MCI from seven countries: Italy, Spain, France, Germany, Switzerland, the UK and the US.
Read more

SiderAL
A new comparative evaluation of different oral iron salts in the management of iron deficiency anemia was published. The Sucrosomial iron showed significantly higher improvement in hemoglobin levels and higher improvement in iron store indices parameters along with a good tolerability profile compared to other conventional oral iron salts.
Access study

Monteloeder’s lemon verbena may improve sleep
RelaxPLX, a pure extract of lemon verbena (Aloysia citrodora) formulated by Monteloeder (SuanNutra), could improve sleep quality in people with sleep problems, concludes a paper in Nutrients (18 May). Researchers from the Catholic University of San Antonio de Murcia and Monteloeder allocated 71 healthy adults to consume either RelaxPLX (400mg/d) vs placebo 1 hour before bedtime for 90 days. Using a Visual Analogue Scale, participants in the RelaxPLX group reported significant improvements in falling asleep and better sleep quality vs placebo. The reports matched results from wearable sleep trackers worn by participants. In addition, nocturnal melatonin levels increased by 14%+ in the RelaxPLX group vs placebo. The study team received funding from Monteloeder.
Access study

Could Kaneka’s Ubiquinol benefit menopausal women?
Kaneka Nutrients’ Ubiquinol, the reduced active antioxidant of CoQ10, could help support women experiencing menopause, according to consumer research. The study, conducted by the research institute Expansion Consulteam, recruited 200 women aged 45-55 who were experiencing menopausal discomfort; recruitment was achieved via Instagram, with help from French lifestyle influencers. Women were excluded if they were taking any hormone treatments, food supplements, or other remedies for menopausal symptoms. For 2 months, participants consumed Ubiquinol 200mg/d and reported their symptoms throughout. At baseline, the most frequently reported symptoms were poor skin quality, sleep disturbance, and stress/anxiety. At study-end, 80% reported mood improvement and feeling more emotionally stable, while 70% reported better sleep quality, less muscular pain, and improved wellbeing. Kaneka Nutrients revealed the findings at Vitafoods Europe (14-16 May).
Read more